Salidroside suppresses the metastasis of hepatocellular carcinoma cells by inhibiting the activation of the Notch1 signaling pathway
Salidroside suppresses the metastasis of hepatocellular carcinoma cells by inhibiting the activation of the Notch1 signaling pathway
复制标题
红景天苷通过抑制Notch1信号通路的激活抑制肝癌细胞的转移
DOI:
10.3892/mmr.2019.10115
复制
发表时间:
2019-06-01
影响因子:
3.4
通讯作者:
Xin, Yongning
中科院分区:
文献类型:
--
作者:
Lu, Linlin;Liu, Shousheng;Xin, Yongning
Salidroside (SDS) is a phenylpropanoid glycoside isolated from Rhodiola rosea L. It exhibits multiple pharmacological properties in clinical medicine and has been commonly used in traditional Chinese medicine. The present study investigated the inhibitory effects of SDS on tumor invasion and migration, and the expression of metastasis-related genes in highly metastatic hepatocellular carcinoma (HCC) cells (MHCC97H) in vitro. The underlying mechanisms of SDS on the tumor metastasis were also explored. SDS was found to significantly reduce wound closure areas and inhibit cell migration. In addition, SDS markedly inhibited the invasion of these cells into Matrigel-coated membranes. SDS markedly downregulated the expression of Notch1, Snail, COX-2, MMP-2, MMP-9 genes and upregulated the expression of E-cadherin in a dose-dependent manner. Furthermore, SDS inhibited the expression of the Notch signaling target genes, Hey1, Hes1 and Hes5. On the whole, the findings of this study suggest that SDS inhibits HCC cell metastasis by modulating the activity of the Notch1 signaling pathway.